Replies to post #18591 on NorthWest Biotherapeutics Inc (NWBO)

[PacificNW]

Sorry too long. Need to be written in bullet points style.
You can always send this this as a follow up to be used for his segment but for now my fear is he will just file it under to be read later when he has time.

[highwayman4life]

I still would like to hear from a few more of you if possible before I send this out to Dr. Siegel

[gnawkz]

Hi Highwayman4life

Your content below is excellent, but I think the flow can be improved.

I think you should move the last section from the bottom of the letter to the top. I read maybe 3-5 sentences of the letter and then automatically transitioned to skimming. It was not clear to me (within 2 mins) what you were requesting or what Dr. Segiel should take from this letter and what he should do next.

Your content below is great, but I think it would be much more effective if these new advancements were positioned as

"How patients are able to MORE EASILY gain access to DCVax-L" vs back in November 2013. This includes the German Hospital Exemption, the 10 Hospitals, and the UK National Initiatives + the FDA compassionate use approval.

In addition, we should de-emphasizes anything that relates to "Pumping" of the stock or new business developments. If new developments can't be positioned as helping more patients faster, then I don't think it should be mentioned.

I don't believe Media doesn't cares about the fact that NWBO is the 1st biotech to obtain HE. But media would DROOL AND SCRAMBLE after a story where a cancer patient got rejected by the FDA but got treatment through HE.

These are just my 2 cents ...

Thanks for doing this.

[Homework.Investwell]

Great Job Highway! Include principal investigators?

UCLA-Linda M. Liau, MD, PhD, who participated in that study, is the
Moffitt Cancer Center Tampa, Fl.-Dr. Arnold Etame is a Neurological Surgeon and Scientist.
MD Anderson-Primary investigator, Dr. Vivek Subbiah
Europe-Dr. Keyoumars Ashkan, The lead site is Kings College Hospital in London.
GERMANY-Fraunhofer Institute, Gabriele Schackert, Prof, Dr.

ALL CLINICAL SITES WEBSITE;
http://www.cancer.gov/clinicaltrials/search/view?cdrid=453379&version=HealthProfessional

[sharpie510]

Hi Scott,

For the paragraph on Allan Butler, it would be informative to include the fact that he was in a very bad state, having his pancreatic cancer spread to both his liver and abdominal cavity, before joining the DCVax-Direct trial.

Thanks for your time.

[Ready4bluesky]

Thanks Highwayman. Good work!

[flipper44]

Thanks for your action oriented approach! I really do think the truth shall prevail. I very much appreciate the way you lay out the ongoing results for Direct. Even though I've read the NWBIO press releases a hundred times, it still knocks my socks off.